A phase II study of vorinostat (MK-0683) in patients with primary myelofibrosis and post-polycythemia vera myelofibrosis

• Christen L. Andersen,
• Nana B. Mortensen,
• Tobias W. Klausen,
• Hanne Vestergaard,
• Ole W. Bjerrum,
• Hans C. Hasselbalch

Affiliations

Christen L. Andersen

Department of Hematology, Roskilde University Hospital, Roskilde

Nana B. Mortensen

Department of Hematology, Roskilde University Hospital, Roskilde

Tobias W. Klausen

Department of Hematology, Herlev University Hospital, Herlev

Hanne Vestergaard

Department of Hematology, Odense University Hospital, Odense

Ole W. Bjerrum

Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

Hans C. Hasselbalch

Department of Hematology, Roskilde University Hospital, Roskilde